| Title |
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
|
|---|---|
| Published in |
ClinicoEconomics and Outcomes Research: CEOR, January 2014
|
| DOI | 10.2147/ceor.s51052 |
| Pubmed ID | |
| Authors |
Daniel T Grima, Stephen T Brown, Laveena Kamboj, Kevin R Bainey, Ron Goeree, Paul Oh, Krishnan Ramanathan, Shaun G Goodman |
| Abstract |
Ticagrelor demonstrated a significant reduction in major cardiac events in patients with acute coronary syndrome (ACS) compared with clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The objective of this study was to assess the cost-effectiveness of ticagrelor compared with clopidogrel in ACS patients from the perspective of the Canadian publicly funded health care system. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| Turkey | 1 | 2% |
| Unknown | 44 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 8 | 17% |
| Student > Doctoral Student | 6 | 13% |
| Researcher | 6 | 13% |
| Other | 4 | 9% |
| Student > Postgraduate | 4 | 9% |
| Other | 10 | 22% |
| Unknown | 8 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 46% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
| Economics, Econometrics and Finance | 3 | 7% |
| Veterinary Science and Veterinary Medicine | 1 | 2% |
| Nursing and Health Professions | 1 | 2% |
| Other | 6 | 13% |
| Unknown | 11 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2020.
All research outputs
#3,379,887
of 25,584,565 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#70
of 514 outputs
Outputs of similar age
#37,566
of 320,237 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#2
of 12 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 514 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,237 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.